gimli

KOVAI stock AI analysis

KOVAI Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

KOVAI MEDICAL CENTER & HO is a small-cap stock in Healthcare. This Gimli page shows the latest available KOVAI price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive KOVAI stock page

Price

₹5,926.00

1W return

-1.16%

1M return

+1.43%

3M return

+7.98%

6M return

n/a

1Y return

n/a

Market cap

₹6,484.41 cr

26.93

4.92

ROE

+20.02%

ROCE

+22.19%

RSI

51.68

Turnover

₹2.06 cr

Why it can matter in screens

Momentum: KOVAI is above 50DMA, below 200DMA; RSI is 51.68.
Returns: 1D -1.00%, 1W -1.16%, 1M +1.43%, 3M +7.98%, 1Y n/a.
Trend levels: 52W high ₹6,205.00, 52W low ₹5,339.00, off high -4.50%.
Liquidity: latest turnover is ₹2.06 cr; volume vs 20D is +0.43%.
Valuation/profitability: PE 26.93, PB 4.92, ROE +20.02%, ROCE +22.19%.
Growth: 3Y sales CAGR +18.24%, 3Y profit CAGR +28.29%.

Quick Answers

What is the latest KOVAI stock price?

The latest stored price for KOVAI is Rs 5,926.00 as of 2026-07-20.

Is KOVAI above its 50DMA and 200DMA?

KOVAI is above 50DMA, below 200DMA. The latest 50DMA is 5,716.31 and the latest 200DMA is n/a.

What are KOVAI PE, ROE and ROCE?

KOVAI has PE 26.93, ROE +20.02%, and ROCE +22.19% in Gimli's latest available snapshot.

How has KOVAI performed recently?

KOVAI has returned +1.43% over 1 month, +7.98% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	413.20 cr	119.05 cr	59.69 cr	54.55
2025-12-31	406.62 cr	123.16 cr	65.02 cr	59.42
2025-09-30	390.74 cr	113.41 cr	58.86 cr	53.79
2025-06-30	373.59 cr	111.49 cr	57.23 cr	52.30
2025-03-31	356.64 cr	107.48 cr	54.70 cr	49.99
2024-12-31	354.70 cr	108.91 cr	57.80 cr	52.83
2024-09-30	n/a	n/a	n/a	46.32

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	1,584.15 cr	467.10 cr	244.46 cr	nan
2025-03-31	1,369.74 cr	407.82 cr	208.95 cr	190.95
2024-03-31	1,133.84 cr	362.48 cr	179.73 cr	164.25
2023-03-31	958.19 cr	284.32 cr	115.77 cr	105.80
2022-03-31	917.82 cr	269.34 cr	104.26 cr	95.28

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	2,066.08 cr	63.72 cr	402.75 cr	1,319.27 cr
2025-03-31	1,799.91 cr	14.30 cr	415.34 cr	1,086.16 cr
2024-03-31	1,438.23 cr	59.60 cr	310.36 cr	888.54 cr
2023-03-31	1,438.12 cr	17.95 cr	510.91 cr	719.04 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	361.83 cr	109.88 cr	n/a
2025-03-31	352.91 cr	-0.18 cr	n/a
2024-03-31	344.13 cr	205.71 cr	n/a
2023-03-31	262.91 cr	135.52 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	469,405.90 cr	40.823336	+14.71%	+15.52%
DIVISLAB	DIVI S LABORATORIES LTD	194,269.92 cr	75.650281	+16.19%	+8.71%
TORNTPHARM	TORRENT PHARMACEUTICALS L	169,405.46 cr	78.319677	+17.18%	+42.14%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	128,040.28 cr	65.380043	+21.03%	+21.93%
CIPLA	CIPLA LTD	116,452.52 cr	30.005339	+11.79%	-2.75%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	115,616.29 cr	23.056854	+17.93%	+17.85%
LUPIN	LUPIN LIMITED	113,320.96 cr	21.221472	+26.83%	+28.27%
MAXHEALTH	MAX HEALTHCARE INS LTD	107,290.40 cr	74.382732	+14.33%	-9.32%

Try these prompts

Analyze KOVAI MEDICAL CENTER & HO with valuation, momentum and industry peers
Compare KOVAI with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-07-20. Not investment advice.